These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11776031)

  • 21. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y; Tanaka F; Wada H; Hitomi S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer.
    Grossi F; Pennucci MC; Serrano J; Frola C; Mereu C; Scolaro T; Ratto GB; Tixi L; Ardizzoni A
    Anticancer Res; 2002; 22(6B):3519-24. PubMed ID: 12552949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
    Zhang X; Sun Y; Huang J
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):137-9. PubMed ID: 10743080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
    Choi IS; Oh DY; Kwon JH; Kim SI; Park SR; Bak JY; Kim JH; Kim DW; Kim YT; Kim TY; You CK; Kim YW; Heo DS; Bang YJ; Sung SW; Park CI; Kim NK
    Jpn J Clin Oncol; 2005 Jan; 35(1):6-12. PubMed ID: 15681597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T; Koga T; Nomiyama H; Hidaka H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC].
    Hua XM; Ren XW; Liu FL; Liu Y; Zhang CJ; Li ZJ; Xu L; Liu JY; Liu YG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):621-5. PubMed ID: 15634526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
    Wakelee HA; Stephenson P; Keller SM; Wagner H; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    Lung Cancer; 2005 Jun; 48(3):389-97. PubMed ID: 15893008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of multimodality induction therapy for locally advanced non-small cell lung cancer].
    Yamada T; Nakashima Y; Tanahashi M; Hikosaka Y; Yoshitomi H; Niwa H
    Kyobu Geka; 2005 Oct; 58(11):969-75. PubMed ID: 16235845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
    Depierre A; Milleron B; Lebeau B; Moro D; Chastang C; Jacoulet P; Paillot N; Quoix E; Janicot H; Lombard JN
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):16-9. PubMed ID: 8209272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M;
    J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM; Mentzer SJ; Yeap BY; Soto R; Baldini EH; Rabin MS; Sugarbaker DJ; Bueno R
    Cancer; 2008 Mar; 112(5):1106-13. PubMed ID: 18286507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical adjuvant chemotherapy base on chemosensitivity in nude mouse subrenal capsule assay for non-small cell lung cancer].
    Wen ZS; Zhang TJ; Rong TH
    Ai Zheng; 2003 Dec; 22(12):1355-8. PubMed ID: 14693069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer].
    Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.